Khalid Al Balushi
About
In The Last Decade
Khalid Al Balushi
18 papers receiving 371 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Pharmacology 104
- Physiology 102
- Molecular Biology 99
- Computational Theory and Mathematics 61
- Organic Chemistry 54
Countries citing papers authored by Khalid Al Balushi
This map shows the geographic impact of Khalid Al Balushi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Al Balushi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Al Balushi more than expected).
Fields of papers citing papers by Khalid Al Balushi
This network shows the impact of papers produced by Khalid Al Balushi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Al Balushi. The network helps show where Khalid Al Balushi may publish in the future.
Co-authorship network of co-authors of Khalid Al Balushi
This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Al Balushi. A scholar is included among the top collaborators of Khalid Al Balushi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Al Balushi. Khalid Al Balushi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 18 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 33 | |
| 6 | 10 | |
| 7 | 30 | |
| 8 | Effect of cross linking agent on sustained release microbeads formulation containing immunosuppressant drug | 1 |
| 9 | 5 | |
| 10 | Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease breakdown → | 164 |
| 11 | 3 | |
| 12 | 0 | |
| 13 | 5 | |
| 14 | 0 | |
| 15 | 25 | |
| 16 | 9 | |
| 17 | 15 | |
| 18 | 24 | |
| 19 | Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis | 3 |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.